BioLine RX Ltd (NASDAQ:BLRX)

1.01
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
0.80
Today|||52-Week Range
1.38
-7.34%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +197.03% increase from the last price of 1.01.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in BioLine RX Ltd. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$0.00
Reporting Date
Mar 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.91%
 
 
 
 
 
 
Growthannually -0.99%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.